Search Results

0 results for 'Robbins Geller Rudman Dowd LLP'

You can use to get even better search results
October 27, 2022 | The Recorder

Proposed Class Action Targets 'Early-Allergen-Introduction' Baby Food

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read
October 18, 2022 | Litigation Daily

Taking Stock of the Shrinking, But Still Massive, Opioid Docket

A half-dozen years after the first cases seeking to hold drug companies, distributors and pharmacies liable for the costs of dealing with the opioid crisis, our colleague Amanda Bronstad gives a thorough rundown of the current state of play.
5 minute read
October 17, 2022 | Law.com

Lawyers Got Billions From Opioid Companies, But Legal Fight Far From Over

Drug companies settled opioid lawsuits for billions of dollars this year, and some filed for bankruptcy, but several closely watched appeals are coming up, and, for some defendants, such as pharmacies, the fight has just begun.
6 minute read
October 13, 2022 | The Recorder

Class Counsel Seeks $182M Attorney Fees Award in Proposed Twitter Securities Settlement

Class counsel from Robbins Geller Rudman & Dowd and Motley Rice are asking for 22.5% of a $809.5 million settlement amount they reached with Twitter's counsel from Cooley and Simpson Thacher & Bartlett.
4 minute read
September 16, 2022 | New York Law Journal

NYSBA Launches Task Force on Digital Economy, Web3 and Metaverse, Says Lawyers Must Get 'In Front of the Issues'

"This technology has the power to significantly change the way we do business, bank, and interact both personally and professionally," said NYSBA President Sherry Levin Wallach.
4 minute read
August 17, 2022 | Law.com

The Fall of Endo? 34 AGs Support $450M Payment From Bankrupt Opioid Manufacturer

Opioid drug manufacturer Endo Pharmaceuticals filed a Chapter 11 petition late Tuesday, agreeing to provide $450 million to state and local governments.
4 minute read
August 17, 2022 | Delaware Business Court Insider

Del. Among 34 AGs Supporting $450M Payment From Bankrupt Opioid Manufacturer

Opioid drug manufacturer Endo Pharmaceuticals filed a Chapter 11 petition late Tuesday, agreeing to provide $450 million to state and local governments.
4 minute read
August 12, 2022 | Litigation Daily

Another Dose of Litigator of the Week Runners-Up and Shout Outs

Top runners-up honors this week go to the team behind a major bench trial win for the city of San Francisco in opioid litigation against Walgreens.
7 minute read
August 11, 2022 | Insurance Coverage Law Center

A 'Fifteen-Year Failure': Walgreens Liable for Contributing to Opioid Crisis in San Francisco, Judge Rules

The bench ruling from U.S. District Judge Charles Breyer marks the first bench trial to find Walgreens liable for public nuisance claims in the nationwide multidistrict litigation stemming from the ongoing opioid epidemic, according to San Francisco City Attorney David Chiu.
6 minute read
August 10, 2022 | The Recorder

A 'Fifteen-Year Failure': Walgreens Liable for Contributing to Opioid Crisis in San Francisco, Judge Rules

The bench ruling from U.S. District Judge Charles Breyer marks the first bench trial to find Walgreens liable for public nuisance claims in the nationwide multidistrict litigation stemming from the ongoing opioid epidemic, according to San Francisco City Attorney David Chiu.
5 minute read

Resources